In accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, AstraZeneca Pharma India has informed that the Trading Window for dealing in the Shares of the Company remains closed from June 16, 2022 and the same shall reopen after 48 hours from the declaration of Unaudited Financial Results of the Company for the quarter ending June 30, 2022.
The above information is a part of company’s filings submitted to BSE.